LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | AZD8055 | 10 | uM | LJP6 | 3 | A07 | 72 | hr | 658 | 80 | 3769 | 0.0212 | -0.5670 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 1 | B12 | 72 | hr | 658 | 3944 | 3705 | 1.0643 | 1.0506 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 2 | B12 | 72 | hr | 658 | 3924 | 3807 | 1.0306 | 1.0239 |
Hs 578T | Sorafenib | 0.04 | uM | LJP6 | 3 | B12 | 72 | hr | 658 | 4034 | 3769 | 1.0701 | 1.0546 |
Hs 578T | Sorafenib | 0.12 | uM | LJP6 | 1 | B11 | 72 | hr | 658 | 4092 | 3705 | 1.1042 | 1.0811 |
Hs 578T | Sorafenib | 0.12 | uM | LJP6 | 2 | B11 | 72 | hr | 658 | 4240 | 3807 | 1.1136 | 1.0868 |
Hs 578T | Sorafenib | 0.12 | uM | LJP6 | 3 | B11 | 72 | hr | 658 | 4083 | 3769 | 1.0831 | 1.0644 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 1 | B10 | 72 | hr | 658 | 4048 | 3705 | 1.0923 | 1.0721 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 2 | B10 | 72 | hr | 658 | 3931 | 3807 | 1.0324 | 1.0254 |
Hs 578T | Sorafenib | 0.37 | uM | LJP6 | 3 | B10 | 72 | hr | 658 | 4050 | 3769 | 1.0744 | 1.0578 |
Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 1 | B09 | 72 | hr | 658 | 3969 | 3705 | 1.0710 | 1.0558 |
Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 2 | B09 | 72 | hr | 658 | 4054 | 3807 | 1.0647 | 1.0501 |
Hs 578T | Sorafenib | 1.11 | uM | LJP6 | 3 | B09 | 72 | hr | 658 | 3827 | 3769 | 1.0152 | 1.0120 |
Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 1 | B08 | 72 | hr | 658 | 3855 | 3705 | 1.0402 | 1.0319 |
Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 2 | B08 | 72 | hr | 658 | 3892 | 3807 | 1.0222 | 1.0174 |
Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 3 | B08 | 72 | hr | 658 | 3910 | 3769 | 1.0372 | 1.0292 |
Hs 578T | Sorafenib | 10 | uM | LJP6 | 1 | B07 | 72 | hr | 658 | 2826 | 3705 | 0.7626 | 0.7940 |
Hs 578T | Sorafenib | 10 | uM | LJP6 | 2 | B07 | 72 | hr | 658 | 2721 | 3807 | 0.7146 | 0.7515 |
Hs 578T | Sorafenib | 10 | uM | LJP6 | 3 | B07 | 72 | hr | 658 | 2708 | 3769 | 0.7184 | 0.7538 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 1 | I12 | 72 | hr | 658 | 4016 | 3908 | 1.0275 | 1.0212 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 2 | I12 | 72 | hr | 658 | 4171 | 3953 | 1.0550 | 1.0418 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 3 | I12 | 72 | hr | 658 | 4216 | 3938 | 1.0705 | 1.0535 |
Hs 578T | CP466722 | 0.12 | uM | LJP5 | 1 | I11 | 72 | hr | 658 | 3845 | 3908 | 0.9838 | 0.9873 |
Hs 578T | CP466722 | 0.12 | uM | LJP5 | 2 | I11 | 72 | hr | 658 | 4163 | 3953 | 1.0529 | 1.0403 |
Hs 578T | CP466722 | 0.12 | uM | LJP5 | 3 | I11 | 72 | hr | 658 | 4177 | 3938 | 1.0606 | 1.0461 |